OctreoPharm, Ipsen deal

Ipsen will acquire radiopharmaceutical company OctreoPharm for about EUR30 million ($34 million) up front and up to about EUR20 million ($22.6 million) in milestones. Ipsen will gain SOMscan ( OPS202...